CULT Food Science Subsidiary Further Foods Submits Trial Design for Cultivated Meat in Pet Food to the FDA
CULT Food Science Corp. (CSE: CULT) (OTC: CULTF) has announced that its subsidiary, Further Foods Inc., has submitted a feeding trial design protocol for dog food products containing cell-cultivated chicken to the FDA. The company aims to start feeding trials in Q4 2024, pending FDA approval. The trial, designed in collaboration with vet nutritionist Dr. Sarah Dodd, is expected to be a 26-week study involving 30 healthy adult dogs of various breeds and ages.
This trial is a important step for Noochies!, a CULT Food Science brand, in its goal to be the first-to-market with cultivated meat pet food in North America. The study will monitor various health indicators to ensure the safety and efficacy of including cell-cultivated meat in pet food products. CULT Food Science anticipates a response from the FDA regarding the approval of the feeding trial design in approximately 45 days.
CULT Food Science Corp. (CSE: CULT) (OTC: CULTF) ha annunciato che la sua controllata, Further Foods Inc., ha presentato un protocollo per un trial alimentare per prodotti di cibo per cani contenenti pollo coltivato in laboratorio all'FDA. L'azienda mira a iniziare i trial alimentari nel quarto trimestre del 2024, in attesa dell'approvazione dell'FDA. Il trial, progettato in collaborazione con la nutrizionista veterinaria Dr. Sarah Dodd, prevede uno studio di 26 settimane che coinvolgerà 30 cani adulti sani di diverse razze e età.
Questo trial rappresenta un passo importante per Noochies!, un marchio di CULT Food Science, nel suo obiettivo di essere il primo sul mercato con cibo per animali domestici a base di carne coltivata in Nord America. Lo studio monitorerà vari indicatori di salute per garantire la sicurezza e l'efficacia dell'inclusione di carne coltivata in laboratorio nei prodotti per animali domestici. CULT Food Science prevede una risposta dall'FDA riguardo all'approvazione del protocollo del trial alimentare in circa 45 giorni.
CULT Food Science Corp. (CSE: CULT) (OTC: CULTF) ha anunciado que su subsidiaria, Further Foods Inc., ha presentado un protocolo de diseño para un ensayo de alimentación de productos de comida para perros que contienen pollo cultivado en laboratorio a la FDA. La compañía tiene como objetivo iniciar los ensayos de alimentación en el cuarto trimestre de 2024, a la espera de la aprobación de la FDA. El ensayo, diseñado en colaboración con la nutricionista veterinaria Dra. Sarah Dodd, se espera que sea un estudio de 26 semanas que involucre a 30 perros adultos sanos de diversas razas y edades.
Este ensayo es un paso importante para Noochies!, una marca de CULT Food Science, en su objetivo de ser el primer en el mercado con comida para mascotas de carne cultivada en América del Norte. El estudio monitoreará varios indicadores de salud para garantizar la seguridad y eficacia de la inclusión de carne cultivada en productos para mascotas. CULT Food Science anticipa una respuesta de la FDA sobre la aprobación del diseño del ensayo de alimentación en aproximadamente 45 días.
CULT Food Science Corp. (CSE: CULT) (OTC: CULTF)는 그 자회사인 Further Foods Inc.가 세포 배양된 닭고기를 포함하는 개 사료 제품에 대한 급여 시험 설계 프로토콜을 FDA에 제출했다고 발표했습니다. 이 회사는 FDA 승인을 기다리며 2024년 4분기에 급여 시험을 시작할 계획입니다. 이 시험은 수의사 영양사인 Sarah Dodd 박사와 협력하여 설계되었으며, 30마리의 건강한 성견을 포함하는 26주 연구로 예상됩니다.
이 시험은 CULT Food Science 브랜드인 Noochies!가 북미에서 배양된 고기 애완 동물 사료를 시장에 처음 선보이는 목표를 위해 중요한 단계입니다. 연구는 애완 동물 사료 제품에 세포 배양 고기를 포함하는 것의 안전성과 효능을 보장하기 위해 다양한 건강 지표를 모니터링할 것입니다. CULT Food Science는 급여 시험 설계에 대한 FDA의 승답을 약 45일 후에 받을 것으로 예상하고 있습니다.
CULT Food Science Corp. (CSE: CULT) (OTC: CULTF) a annoncé que sa filiale, Further Foods Inc., a soumis un protocole de conception d'essai d'alimentation pour des produits alimentaires pour chiens contenant du poulet cultivé en laboratoire à la FDA. La société vise à commencer les essais d'alimentation au quatrième trimestre 2024, sous réserve de l'approbation de la FDA. L'essai, conçu en collaboration avec la nutritionniste vétérinaire Dr. Sarah Dodd, devrait être une étude de 26 semaines impliquant 30 chiens adultes en bonne santé de différentes races et âges.
Cette étude est une étape importante pour Noochies!, une marque de CULT Food Science, dans son objectif de devenir le premier sur le marché avec de la nourriture pour animaux de compagnie à base de viande cultivée en Amérique du Nord. L'étude surveillera divers indicateurs de santé pour garantir la sécurité et l'efficacité de l'inclusion de viande cultivée dans les produits alimentaires pour animaux de compagnie. CULT Food Science prévoit une réponse de la FDA concernant l'approbation du design de l'essai d'alimentation dans environ 45 jours.
CULT Food Science Corp. (CSE: CULT) (OTC: CULTF) hat angekündigt, dass ihre Tochtergesellschaft Further Foods Inc. ein Protokoll für eine Fütterungsstudie zu Hundefutterprodukten mit zellkultiviertem Hühnerfleisch bei der FDA eingereicht hat. Das Unternehmen plant, im vierten Quartal 2024 Fütterungsstudien zu starten, vorbehaltlich der Genehmigung durch die FDA. Die Studie, die in Zusammenarbeit mit der Tierernährungswissenschaftlerin Dr. Sarah Dodd entworfen wurde, wird als 26-wöchige Studie mit 30 gesunden erwachsenen Hunden verschiedener Rassen und Altersgruppen erwartet.
Diese Studie ist ein wichtiger Schritt für Noochies!, eine Marke von CULT Food Science, mit dem Ziel, das erste auf dem Markt zu sein mit zellkultiviertem Fleisch für Haustierfutter in Nordamerika. Die Studie wird verschiedene Gesundheitsindikatoren überwachen, um die Sicherheit und Wirksamkeit der Aufnahme von zellkultiviertem Fleisch in Haustierfutterprodukten sicherzustellen. CULT Food Science erwartet eine Antwort von der FDA bezüglich der Genehmigung des Fütterungsstudienprotokolls in etwa 45 Tagen.
- Further Foods is potentially the first company in dialogue with the FDA about feeding trials for cultivated chicken dog treats
- The company aims to be first-to-market with cultivated meat pet food in North America
- Collaboration with leading vet nutritionist Dr. Sarah Dodd ensures high standards for the feeding trial
- The feeding trials are not yet approved and are pending FDA review
- The actual start of feeding trials is projected for Q4 2024, indicating a significant wait time before potential product launch
- As a first-of-its-kind trial, there may be unforeseen challenges or regulatory hurdles
The Company anticipates a response from the FDA for the approval of the feeding trial design in approximately 45 days
Key Takeaways
- The protocol for Further Foods' first of its kind feeding trial to scientifically validate cultivated chicken in dog food products has been officially completed and submitted to the FDA. Further Foods aims to start feeding trials in Q4 2024, pending approval of the protocol from the FDA.
- Further Foods continues to collaborate with leading vet nutritionist Dr. Sarah Dodd on all aspects of the feeding trial in order to ensure the highest standards of safety and nutritional efficacy.
- This feeding trial is a crucial step towards Noochies! bringing cultivated meat pet food products to pet owners in
North America , ensuring it is safe and effective.
The trial is anticipated to be a 26-week, minimally invasive study involving 30 healthy, adult dogs of various breeds and ages. The trial will monitor feed intake data, hematology, serum biochemistry, urinalysis, weight, fecal analysis, and digestibility factors to ensure the inclusion of cell-cultivated meat is safe for the animals. Further Foods has partnered with Dr. Sarah Dodd to ensure the feeding trial design meets all FDA requirements.
Further Foods intends to begin the feeding trials in Q4 2024, once the FDA is satisfied with the design of the protocol. As far as the Company is aware, Further Foods is the only company currently in dialogue with the FDA about feeding trials for a cultivated chicken dog treat.
Noochies!, a brand under CULT Food Science, is aiming to be the first-to-market with cultivated meat pet food in
Management Commentary
Mitchell Scott, CEO of CULT Food Science, stated, "Completing and submitting the feeding trial design to the FDA is a critical step towards bringing cultivated meat to the pet food market. A successful trial could significantly change the landscape of pet food, offering nutritional, environmental, and ethical benefits for pet owners. We are excited to be at the forefront of this innovation and look forward to advancing this trial in collaboration with Dr. Sarah Dodd and the FDA."
About CULT Food Science
CULT Food Science is a disruptive food technology platform pioneering the commercialization of lab grown meat and cellular agriculture to reshape the global food industry. CULT's robust portfolio of investments in cutting-edge, venture-backed cellular agriculture and lab-grown meat companies provides widespread investor access to the future of food. Backed by a team of experts with extensive experience in food technology and launching consumer food products, CULT is committed to being at the forefront of the food revolution.
About Further Foods
Further Foods is revolutionizing pet nutrition through its innovative brand, Noochies! Noochies! leverages advanced cellular agriculture technologies to create pet food products with superior nutrition profiles and ethical standards. Noochies! recently introduced the world's first freeze-dried, high-protein, nutrient-rich pet treats made without factory farming. Noochies! products are currently available for sale in
Additional information can be found by viewing the Company's website at cultfoodscience.com or its regulatory filings on sedar.com.
On behalf of the Board of Directors of the Company,
CULT FOOD SCIENCE CORP.
"Mitchell Scott"
Mitchell Scott, Chief Executive Officer
Forward-Looking Information:
Information set forth in this news release may involve forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company's expected future business and financial performance, and often contain words such as "anticipate", "believe", "plan", "estimate", "expect", and "intend", statements that an action or event "may", "might", "could", "should", or "will" be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include but are not limited to the following risks: those associated with marketing and sale of securities; the need for additional financing; reliance on key personnel; the potential for conflicts of interest among certain officers or directors with certain other projects; and the volatility of common share price and volume. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date that statements are made and except as required by law, the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements. For further information on risk, investors are advised to see the Company's MD&A and other disclosure filings with the regulators which are found at sedar.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cult-food-science-subsidiary-further-foods-submits-trial-design-for-cultivated-meat-in-pet-food-to-the-fda-302217763.html
SOURCE Cult Food Science Corp
FAQ
What is the purpose of the feeding trial submitted by Further Foods to the FDA?
When does CULT Food Science (CULTF) expect to begin the feeding trials for its cultivated meat pet food?
How long will the feeding trial for CULT Food Science's (CULTF) cultivated meat pet food last?
What will be monitored during the feeding trial for CULT Food Science's (CULTF) cultivated meat pet food?
